Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

203 filings reported holding NRIX - Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2024.
Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 67,877,304 shares of 77,143,980 outstanding shares and own 88% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (7,181,535 shares), Redmile Group, LLC (4,280,981 shares), VANGUARD GROUP INC (4,011,814 shares), BAKER BROS. ADVISORS LP (3,882,125 shares), Deep Track Capital, LP (3,868,104 shares), WELLINGTON MANAGEMENT GROUP LLP (3,482,105 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,068,961 shares), T. Rowe Price Investment Management, Inc. (2,548,091 shares), STATE STREET CORP (2,371,271 shares), and ARK Investment Management LLC (2,216,365 shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.